BrainsWay Ltd - American Depositary Shares — Liquidità (NASDAQ:BWAY)

Financials

Flusso di cassa derivante dalle attività operative 1.44 M884 K9.76 M1.28 M10.3 M — Flussi di cassa derivanti dalle attività di investimento 2.46 M42.22 M42.17 M37.41 M30.31 M — Liquidità derivante dalle attività di finanziamento 1.03 M41.52 M1.55 M1.03 M18.26 M — Liquidità libera 1.44 M884 K9.76 M1.28 M10.3 M —

BrainsWay Ltd - American Depositary Shares

BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem.

BWAY

Financials

BrainsWay Ltd - American Depositary Shares

Notizie

Are Medical Stocks Lagging Alcon (ALC) This Year?

Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know

Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why

New Strong Buy Stocks for April 13th

Are Medical Stocks Lagging ArriVent BioPharma, Inc. (AVBP) This Year?

BrainsWay completa prestito convertibile da 6 milioni di dollari a Neurolief

BrainsWay completa investimento da 1 milione $ in società di salute mentale del Colorado

H.C. Wainwright riduce il target di Brainsway a $15 per cambio ratio ADS

Brainsway stock price target cut to $15 by H.C. Wainwright on ADS ratio change

BrainsWay Ltd. (BWAY) Q4 2025 Earnings Call Transcript

Gli EPS di Brainsway hanno battuto le aspettative per 0,02$, il fatturato supera le previsioni

Brainsway earnings beat by $0.02, revenue topped estimates